Hydrocephalus in a fetus develops when cerebrospinal fluid (CSF) builds up inside the brain’s ventricles, the small chambers that normally produce and circulate this fluid. The buildup happens for one of three reasons: something blocks the fluid’s normal drainage path, the brain can’t absorb the fluid properly, or (rarely) the brain produces too much of it. The global incidence ranges from about 2 to 18 per 10,000 live births, and the causes span structural problems, genetic conditions, infections, and bleeding in the brain.
How Fluid Builds Up in the Fetal Brain
The fetal brain continuously produces cerebrospinal fluid inside its ventricles. That fluid flows through narrow channels, circulates around the brain and spinal cord, and gets reabsorbed into the bloodstream. When any part of this loop fails, fluid accumulates and the ventricles swell, putting pressure on surrounding brain tissue.
The most common mechanism is obstruction. A narrow passageway called the cerebral aqueduct connects the third and fourth ventricles, and it’s small enough that even minor narrowing or blockage stops fluid from draining. This single bottleneck accounts for a large share of fetal hydrocephalus cases. Less often, inflammation or hemorrhage damages the tissue responsible for reabsorbing fluid, or a genetic defect causes the fluid-producing cells to become overactive.
Aqueductal Stenosis
Aqueductal stenosis, the narrowing or complete blockage of the cerebral aqueduct, is one of the most significant structural causes. It typically develops early in gestation and is considered multifactorial, meaning several things can contribute at once. Abnormal brain growth or malformations near the aqueduct can physically compress it. Chronic inflammation from infection or immune responses can scar and narrow the channel. Exposure to certain harmful substances during pregnancy (teratogens) can also interfere with normal development of the passage.
Once the aqueduct narrows enough, fluid backs up in the ventricles above it. The resulting pressure can cause secondary brain damage and disrupt normal brain development, which is why early detection matters.
Neural Tube Defects and Chiari Malformation
Spina bifida, specifically the form called myelomeningocele, is closely linked to hydrocephalus through a chain reaction that begins when the neural tube fails to close properly. This failure leads to a condition called Chiari II malformation, where part of the hindbrain is pulled downward through the opening at the base of the skull. As the hindbrain herniates, it becomes compressed and impacted, eventually blocking CSF from flowing out of the brain’s fourth ventricle and into the spinal canal.
Animal studies have shown that creating an artificial spina bifida lesion causes the hindbrain to descend, and repairing the lesion in utero can reverse it. This is part of the rationale behind fetal surgery for spina bifida, which aims to reduce the severity of both the spinal defect and the resulting hydrocephalus. The restricted space in the back of the skull progressively worsens the herniation until the ventricles begin to enlarge.
Genetic Causes
Several genetic conditions cause hydrocephalus, but the best understood is L1 syndrome, an X-linked condition caused by mutations in the L1CAM gene. Because it’s X-linked, it primarily affects male fetuses. The hallmark features include hydrocephalus (often detectable before birth), muscle stiffness, and thumbs that are permanently bent inward toward the palms. The hydrocephalus in L1 syndrome results from aqueductal stenosis caused by the faulty gene’s effect on brain cell development.
The severity depends on the type of mutation. Some mutations completely eliminate the protein the gene produces, leading to severe hydrocephalus and significant intellectual disability. Others alter the protein’s structure without destroying it entirely, resulting in milder forms with less pronounced symptoms. Other genes involved in cilia function and neural tube development have also been implicated. Tiny hair-like structures called cilia line the brain’s ventricles and help move cerebrospinal fluid. When the genes controlling these cilia are defective, fluid movement stalls and hydrocephalus can develop.
Maternal Infections
Certain infections that cross the placenta can inflame and damage the fetal brain, leading to hydrocephalus. The most relevant ones fall under the TORCH group of infections:
- Toxoplasmosis can cause intracranial calcifications, hydrocephalus, and microcephaly in the fetus. It spreads through undercooked meat or contact with cat feces.
- Cytomegalovirus (CMV) is one of the most common congenital infections and can cause inflammation and calcifications around the ventricles. CMV can also cause scarring of neural tissue that narrows the cerebral aqueduct.
- Zika virus causes significant central nervous system damage, including intracranial calcifications and brain malformations associated with fluid buildup.
These infections cause damage through inflammation and scarring. When inflamed tissue heals, scar tissue can block the narrow fluid pathways or impair the brain’s ability to reabsorb cerebrospinal fluid. The timing of infection during pregnancy influences the severity: infections earlier in gestation tend to cause more extensive damage.
Bleeding in the Fetal Brain
Hemorrhage inside the fetal brain, particularly within or near the ventricles, can trigger hydrocephalus. Most documented cases of in-utero hemorrhage occur in the third trimester, but research has shown that even small, undetectable bleeds earlier in pregnancy can cause the condition. In autopsy studies, blood clots were found lodged at the entrance to the cerebral aqueduct, confirming they were the cause of the obstruction rather than a consequence of it.
Several maternal factors raise the risk of fetal brain bleeding: blood clotting disorders, low platelet counts, poorly controlled diabetes (which can impair fetal blood clotting), pre-eclampsia, use of blood-thinning medications, infections, and even minor abdominal trauma. In some cases, the fetus itself has a clotting disorder, such as thrombocytopenia, that makes bleeding more likely.
How It’s Detected During Pregnancy
Fetal hydrocephalus is typically spotted on routine ultrasound by measuring the width of the lateral ventricles. Normal ventricles measure under 10 millimeters. A measurement of 10 to 12 mm is considered mild or borderline ventriculomegaly. Moderate ventriculomegaly falls between 13 and 15 mm, and anything above 15 mm is classified as severe. There is some variation in how different centers define these cutoffs, with some grouping 10 to 15 mm together as “mild.”
Once enlarged ventricles are found, the next step is determining whether the hydrocephalus is isolated (no other abnormalities) or non-isolated (accompanied by other brain or body malformations). This distinction is critical because it shapes the outlook. MRI can provide more detailed images of the fetal brain, and genetic testing, including whole genome or exome analysis, can identify underlying conditions like L1 syndrome.
What the Diagnosis Means for Outcomes
The prognosis depends heavily on three factors: how large the ventricles are, how early in pregnancy the condition is diagnosed, and whether other abnormalities are present. Isolated mild ventriculomegaly, where ventricles measure between 10 and 12 mm with no other findings, is associated with high survival rates and generally favorable neurodevelopmental outcomes. Isolated moderate ventriculomegaly also often has a positive outcome, though the uncertainty increases.
Moderate to severe cases and non-isolated cases, where hydrocephalus accompanies other structural or genetic problems, carry markedly poorer survival rates and neurodevelopmental outcomes. Key prognostic factors for normal development include later gestational age at diagnosis, ventricle diameters under 13 mm, and the absence of other brain or body anomalies. Even in isolated cases, there remains some risk of developmental differences, so ongoing monitoring is standard.
Treatment Options Before and After Birth
Most hydrocephalus treatment happens after delivery, typically through surgical placement of a shunt (a thin tube that drains excess fluid) or a procedure that creates a new drainage pathway in the brain. Prenatal surgical intervention remains experimental and is not standard care.
A systematic review of fetal surgical approaches found data on 172 cases across 12 studies. The majority, 131 fetuses, received a ventriculoamniotic shunt, a device placed to drain fluid from the brain into the amniotic sac. Shunt failure occurred in about 32% of cases, and perinatal complications included fetal death and preterm birth. A smaller group of 14 fetuses underwent an endoscopic procedure to create an alternative drainage route, with 11 of those procedures succeeding. Developmental outcomes were better when hydrocephalus was isolated, such as cases caused by aqueductal stenosis alone, but the overall quality of long-term outcome data remains limited. Advances in fetal imaging and genetic testing may eventually help identify which specific cases could benefit from prenatal intervention.